2014-2020年中国生物制药行业银行信贷风险评估报告

全国统一服务热线400-666-1917400-788-9700更多报告请访问2014-2020年中国生物制药行业银行信贷风险评估报告

一、调研说明中商情报网全新发布的《2014-2020年中国生物制药行业银行信贷风险评估报告》主要依据国家统计局、国家发改委、商务部、中国海关、国务院发展研究中心、行业协会、工商、税务、海关、国内外相关刊物的基础信息以及行业研究单位等公布和提供的大量资料，结合深入的市场调研资料，由中商情报网的资深专家和研究人员的分析。首先，报告对本行业的特征及国内外市场环境进行描述，其次，对本行业的上下游产业链，市场供需状况及竞争格局等进行了细致的详尽剖析，接着报告中列出数家该行业的重点企业，并分析相关经营财务数据。最后，对该行业未来的发展前景，投资风险及投资策略给出科学的建议。本报告是行业生产、贸易、经销等企业在激烈的市场竞争中洞察市场先机，根据市场需求及时调整经营策略，为战略投资者选择恰当的投资时机和公司领导层做战略规划提供了准确的市场情报信息及科学的决策依据。报告名称2014-2020年中国生物制药行业银行信贷风险评估报告出版日期动态更新报告格式PDF电子版或纸介版交付方式Email发送或EMS快递中文价格印刷版7500元电子版7800元中文印刷版+电子版8000元订购热线400-666-1917400-788-9700【版权声明】本报告由中商情报网出品，报告版权归中商智业公司所有。本报告是中商智业公司的研究与统计成果，报告为有偿提供给购买报告的客户使用。未获得中商智业公司书面授权，任何网站或媒体不得转载或引用，否则中商智业公司有权依法追究其法律责任。如需订阅研究报告，请直接联系本网站，以便获得全程优质完善服务。中商智业公司是中国拥有研究人员数量最多，规模最大，综合实力最强的咨询研究机构，公司每天都会接受媒体采访及发布大量产业经济研究成果。在此，我们诚意向您推荐一种“鉴别咨询公司实力的主要方法”。了解中商情报网实力:门户网站引用电视媒体报道招股说明书引用权威机构引用研究员专区

中商情报网主营业务:IPO上市咨询商业计划书可行性研究研究报告管理咨询营销策划企业培训市场调研产业园区规划政府课题二、研究报告目录

第一章生物制药行业基本特征分析

1.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业界定及主要产品1.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药的定义及分类1.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业的定义

1.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物制药行业特征1.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">中国生物制药产业发展现状1.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">中国生物医药产业运行特征透析1.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物医药产业基地初具规模1.2.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物医药产业结构日趋合理1.2.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物医药产业发展模式分析

1.3mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">世界生物制药业发展特点与形势1.3.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">全球生物制药产业发展近况1.3.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">世界生物制药研发重心向中国转移1.3.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">经济低迷状态下美国生物制药研发继续提速1.3.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">欧洲生物仿制药行业迎来发展契机1.3.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">印度生物医药领域成跨国企业并购焦点1.3.6"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">新加坡当局积极扶持生物制药产业发展

mso-hansi-font-family:"TimesNewRoman"">第二章生物制药行业发展环境分析

2.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">宏观经济环境

2.1.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2013mso-hansi-font-family:"TimesNewRoman"">年中国经济持续良好发展态势

2.1.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2014mso-hansi-font-family:"TimesNewRoman"">年中国宏观经济发展形势透析2.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">中国经济发展面临的机遇与挑战2.1.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">“十二五”期间中国经济走向分析

2.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">社会环境2.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业发展社会环境概述2.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国居民收入与保健意识变化趋势2.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">城镇化与老龄化进程对用药需求影响分析2.2.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">未来疾病发生和发展趋势分析

mso-hansi-font-family:"TimesNewRoman"">第三章生物制药来源及细分行业情况分析

3.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药来源情况3.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">人体来源的药物3.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">动物来源的药物3.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">植物来源的药物3.1.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">海洋生物药物

3.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药细分产业发展情况3.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">血液制品3.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">疫苗3.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">基因工程药物3.2.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">抗体工程药物3.2.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">诊断试剂

mso-hansi-font-family:"TimesNewRoman"">第四章生物制药产业政策对行业的影响

4.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">国际生物制药产业政策4.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">国际生物制药产业发展的政策环境综述4.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">美国对生物医药产业的法规管治4.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">欧洲生物仿制药行业政策导向4.1.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">丹麦对生物制药行业的扶持政策解析

4.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">中国生物制药行业发展的政策环境4.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物制药产业政策扶持力度持续升级4.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物制药行业的政治法律环境剖析4.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">部分政策对生物制药行业的影响分析4.2.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">国家对生物制药行业的政策趋势探析

mso-hansi-font-family:"TimesNewRoman"">第五章

宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业预测分析

5.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业发展趋势5.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">世界生物医药产业发展趋势5.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">中国生物制药产业发展前景光明5.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物制药产业机遇与挑战并存5.1.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">我国生物制药行业发展趋势分析

5.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">

2014-2020"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年生物生化制品制造行业关键指标定量预测5.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">市场需求预测5.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">供给能力预测5.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">盈利能力预测

mso-hansi-font-family:"TimesNewRoman"">第六章生物生化制品制造行业总体经济状况

6.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业总体状况

6.1.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2012mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月生物生化制品制造行业总体数据分析

6.1.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2013mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月生物生化制品制造行业总体数据分析

6.1.3mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2014mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月生物生化制品制造行业总体数据分析

6.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">不同所有制企业构成状况

6.2.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2013mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月行业不同所有制企业构成情况

6.2.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2014mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月行业不同所有制企业构成情况

6.3mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">不同规模企业构成状况

6.3.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2013mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月行业不同规模企业构成情况

6.3.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">2014mso-hansi-font-family:"TimesNewRoman"">年1-12"TimesNewRoman"">月行业不同规模企业构成情况

mso-hansi-font-family:"TimesNewRoman"">第七章生物生化制品制造行业财务状况分析

7.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业偿债能力分析7.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业总体偿债能力分析7.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同所有制企业偿债能力比较分析7.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同规模企业偿债能力比较分析

7.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业盈利能力分析7.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业总体盈利能力分析7.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同所有制企业盈利能力比较分析7.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同规模企业盈利能力比较分析

7.3mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业营运能力分析7.3.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业总体营运能力分析7.3.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同所有制企业营运能力比较分析7.3.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同规模企业营运能力比较分析

7.4mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业成长能力分析7.4.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业总体成长能力分析7.4.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同所有制企业成长能力比较分析7.4.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业内不同规模企业成长能力比较分析

7.5mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">关于生物生化制品制造行业财务状况的结论7.5.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业总体财务状况7.5.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">不同所有制企业财务状况7.5.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">不同规模企业财务状况

mso-hansi-font-family:"TimesNewRoman"">第八章生物制药行业重点企业财务状况

8.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">紫光古汉集团股份有限公司8.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司概况8.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司偿债能力分析8.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司盈利能力分析8.1.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司营运能力分析8.1.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司成长能力分析

8.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">北京天坛生物制品股份有限公司8.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司概况8.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司偿债能力分析8.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司盈利能力分析8.2.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司营运能力分析8.2.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司成长能力分析

8.3mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">深圳市海王生物工程股份有限公司8.3.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司概况8.3.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司偿债能力分析8.3.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司盈利能力分析8.3.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司营运能力分析8.3.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司成长能力分析

8.4mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">金花企业（集团）股份有限公司8.4.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司概况8.4.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司偿债能力分析8.4.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司盈利能力分析8.4.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司营运能力分析8.4.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司成长能力分析

8.5mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">上海复星医药（集团）股份有限公司8.5.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司概况8.5.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司偿债能力分析8.5.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司盈利能力分析8.5.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司营运能力分析8.5.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司成长能力分析

8.6mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">华兰生物工程股份有限公司8.6.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司概况8.6.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司偿债能力分析8.6.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司盈利能力分析8.6.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司营运能力分析8.6.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">公司成长能力分析

mso-hansi-font-family:"TimesNewRoman"">第九章

宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业银行信贷建议

9.1mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业信用风险五因子评级模型9.1.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">行业定位9.1.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">宏观环境9.1.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">财务状况9.1.4"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">需求空间9.1.5"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">供给约束9.1.6"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">关于生物制药行业信用风险评级的结论

9.2mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">

"TimesNewRoman"">生物制药行业总体及不同规模的信贷建议9.2.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业总体信贷建议9.2.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">大型企业信贷建议9.2.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">中小企业信贷建议

9.3mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">

"TimesNewRoman"">生物制药行业不同所有制企业的信贷建议9.3.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">国有企业信贷建议9.3.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">私营企业信贷建议9.3.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">股份制企业信贷建议

9.4mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">

"TimesNewRoman"">生物制药行业信贷风险提示9.4.1"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业面临的经济风险9.4.2"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业面临的政策风险9.4.3"TimesNewRoman"">mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">生物制药行业面临的技术风险

mso-hansi-font-family:"TimesNewRoman"">图表目录

mso-hansi-font-family:"TimesNewRoman"">图表医药行业分类及代码

mso-hansi-font-family:"TimesNewRoman"">图表全球前五名生物畅销药剂型

mso-hansi-font-family:"TimesNewRoman"">图表全球前五名化学畅销药剂型

mso-hansi-font-family:"TimesNewRoman"">图表国内生产总值及增速

mso-hansi-font-family:"TimesNewRoman"">图表粮食产量及增速

mso-hansi-font-family:"TimesNewRoman"">图表规模以上工业增加值月度同比增长速度

mso-hansi-font-family:"TimesNewRoman"">图表全部工业增加值及增速

mso-hansi-font-family:"TimesNewRoman"">图表规模以上工业企业实现利润及增速

mso-hansi-font-family:"TimesNewRoman"">图表城镇固定资产投资累计同比增长速度

mso-hansi-font-family:"TimesNewRoman"">图表全社会固定资产投资及增速

mso-hansi-font-family:"TimesNewRoman"">图表社会消费品零售总额月度同比增长速度

mso-hansi-font-family:"TimesNewRoman"">图表社会消费品零售总额及增速

mso-hansi-font-family:"TimesNewRoman"">图表居民消费价格月度同比涨跌幅度

mso-hansi-font-family:"TimesNewRoman"">图表居民消费价格涨跌幅度

mso-hansi-font-family:"TimesNewRoman"">图表农村居民人均纯收入及增速

mso-hansi-font-family:"TimesNewRoman"">图表城镇居民人均可支配收入及增速

mso-hansi-font-family:"TimesNewRoman"">图表城乡居民家庭人均医疗保健消费性支出变化

mso-hansi-font-family:"TimesNewRoman"">图表国内干扰素市场规模及成长率

mso-hansi-font-family:"TimesNewRoman"">图表重组人干扰素注射剂产品市场份额

mso-hansi-font-family:"TimesNewRoman"">图表重组人干扰素栓剂产品市场份额

mso-hansi-font-family:"TimesNewRoman"">图表重组人干扰素滴眼液产品市场份额

mso-hansi-font-family:"TimesNewRoman"">图表重组人干扰素乳膏产品市场份额

mso-hansi-font-family:"TimesNewRoman"">图表国内生长激素市场规模及成长率

mso-hansi-font-family:"TimesNewRoman"">图表重组人生长激素制剂市场份额

mso-hansi-font-family:"TimesNewRoman"">图表我国生物制药占医药工业比例

mso-hansi-font-family:"TimesNewRoman"">图表我国抗体药物占生物制药比例

mso-hansi-font-family:"TimesNewRoman"">图表我国已批准的抗体药物

mso-hansi-font-family:"TimesNewRoman"">图表中国体外诊断试剂产品格局

mso-hansi-font-family:"TimesNewRoman"">图表国内主要体外诊断试剂产品细分市场竞争格局

mso-hansi-font-family:"TimesNewRoman"">图表2007-2014"TimesNewRoman"">年中国生化试剂市场规模增长情况

mso-hansi-font-family:"TimesNewRoman"">图表2007-2014"TimesNewRoman"">年中国免疫诊断试剂市场规模增长情况

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业总体数据

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业总体数据

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业总体数据

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业构成情况

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计资产总计对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计产品销售收入对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计工业总产值对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计利润总额对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业构成情况

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计资产总计对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计产品销售收入对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业累计利润总额对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业构成情况

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计资产总计对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计产品销售收入对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计工业总产值对比

mso-hansi-font-family:"TimesNewRoman"">图表2013"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计利润总额对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业构成情况

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计资产总计对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计产品销售收入对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同规模企业累计利润总额对比

mso-hansi-font-family:"TimesNewRoman"">图表2012-2014"TimesNewRoman"">年生物生化制品制造行业资产负债率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012-2014"TimesNewRoman"">年生物生化制品制造行业产权比率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同所有制企业资产负债率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同所有制企业产权比率对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同所有制企业资产负债率对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同所有制企业产权比率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同规模企业资产负债率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同规模企业产权比率对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同规模企业资产负债率对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业内不同规模企业产权比率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012-2014"TimesNewRoman"">年生物生化制品制造行业销售利润率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012-2014"TimesNewRoman"">年生物生化制品制造行业净资产收益率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012-2014"TimesNewRoman"">年生物生化制品制造行业总资产收益率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业销售利润率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业净资产收益率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业总资产收益率对比

mso-hansi-font-family:"TimesNewRoman"">图表2012"TimesNewRoman"">、2013宋体;mso-ascii-font-family:"TimesNewRoman";mso-hansi-font-family:"TimesNewRoman"">年1-12mso-hansi-font-family:"TimesNewRoman"">月生物生化制品制造行业不同所有制企业资金利税率对比

mso-hansi-font-family:"TimesNewRoman"">图表2014"TimesNewRoman"">年1-12宋体;mso-ascii-font-family:"TimesNewRoman";ms